Protocol Ledger

NCT05415462 · Phase III · COMPLETED

A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Interventional Phase III clinical trial protocol NCT05415462 sponsored by ModernaTX in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-06-06 Enrollment: 6,102 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05415462
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)6,102 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05415462
Protocol FieldVerified Registry Value
NCT IdentifierNCT05415462
Consolidated Lead SponsorModernaTX
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment6,102 participants (ACTUAL)
Registered Start Date2022-06-06
WhyStopped ClassificationNot Stopped

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Moderna across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI